Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Process for the preparation of polymorphs of selective serotonin reuptake inhibitor

A technology of crystal form and solvent is applied in the field of preparation of selective serotonin reuptake inhibitor polymorph, and can solve the problems of undisclosed solid state properties of sertraline hydrochloride and the like

Inactive Publication Date: 2007-01-24
CIPLA LTD
View PDF11 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But this patent does not disclose the solid-state proper

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for the preparation of polymorphs of selective serotonin reuptake inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Preparation of Sertraline Hydrochloride Form II

[0041] 20 grams of sertraline acetate was suspended in a mixture of 100 ml of isopropanol and 4 ml of toluene. The mixture was heated to 50°C to obtain a clear solution, and dried hydrogen chloride gas was introduced to adjust the pH to 1-2. The reaction exothermed and the temperature rose to 60°C. The reaction was gradually cooled to room temperature. The precipitated solid was filtered and washed with isopropanol, and dried in a vacuum at 80° C. for 4 to 5 hours to obtain Sertraline Hydrochloride Form II.

Embodiment 2

[0043] Preparation of Sertraline Hydrochloride Form III

[0044] 20 grams of sertraline acetate was suspended in a mixture of 100 ml of isopropanol and 4 ml of toluene. The mixture was heated to 50°C to obtain a clear solution, and dried hydrogen chloride gas was passed through to adjust the pH to 1-2. The reaction exothermed and the temperature rose to 60°C. The reaction mixture was quickly cooled to 15-20°C in an ice bath within 15-20 minutes. The precipitated solid was filtered, washed with isopropanol, and dried in vacuum at 80° C. for 4 to 5 hours to obtain Sertraline Hydrochloride Form III.

Embodiment 3

[0046] Preparation of Sertraline Hydrochloride Form IV

[0047] Suspend 50 grams of sertraline acetate in 250 ml of isopropanol at room temperature. The mixture was heated to 50°C to obtain a clear solution, and dried hydrogen chloride gas was passed in to adjust the pH to 1-2. The reaction mixture was cooled to 15-20°C within 30 minutes with stirring. The precipitated solid is filtered and washed with isopropanol, and dried in a fluidized bed dryer at 60° C. for 4 to 5 hours to obtain Sertraline Hydrochloride Form IV.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to sertraline hydrochloride crystal forms II, III, IV and V and a preparation method thereof. According to the present invention, various polymorphs of sertraline hydrochloride can be prepared directly from sertraline base or from sertraline acetate.

Description

Technical field [0001] The invention relates to a method for preparing various polymorphs of sertraline hydrochloride from sertraline base or sertraline acetate. The method is rugged and is suitable for mass production of various crystal forms of sertraline hydrochloride, that is, crystal forms II, III, IV and V. Background technique [0002] Sertraline hydrochloride with formula 1, (1S-cis)-4-(3,4 dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthylamine hydrochloride It is approved by the U.S. Food and Drug Administration for the treatment of depression, obsessive-compulsive disorder and panic disorder, with the trade name Zoloft(R). [0003] [0004] Formula 1 [0005] U.S. Patent No. 4,536,518 ("the '518 Patent") describes the preparation of sertraline hydrochloride with a melting point of 243-245°C by treating an ethyl acetate / ether solution of free base with hydrogen chloride gas. However, the patent does not disclose the solid-state prope...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C209/84C07C211/42A61K31/135
CPCC07C209/84A61P25/22A61P25/24A61P43/00C07C211/42
Inventor 德哈马拉杰·拉马钱德拉·拉奥拉金德拉·纳拉扬拉奥·坎坎
Owner CIPLA LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com